STOCKBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Updated 2026-07-26
Here’s whether Amgen Inc (AMGN) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.92% over 10 days); RSI 60 — healthy momentum range; strong 1-year return of +21.9%; 3-month momentum positive (+9.1%). Currently 3.9% off its 52-week high. Score: +7/7.
AMGN is in a confirmed uptrend, trading above both its 50-day ($350.23) and 200-day ($341.52) moving averages. An RSI of 59.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +21.9% compares to +16.5% for SPY (beat the market by 5.4%).
$10,000 invested 1 year ago→ $12,187 today
vs. S&P 500 (SPY) — same period beat market by 5.4%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($341.52)
✓Above 50-day MA ($350.23)
✓RSI(14) neutral zone (30–70) — currently 59.5
✓Positive return (+21.9%)
✓Within 10% of period high (−3.9%)
Period Range $376.04
$269.77$391.29
RSI (14) 59.5
0 · OversoldOverbought · 100
Key Metrics
Price$376.04
Period Return+21.9%
Period High$391.29
Period Low$269.77
Drawdown−3.9%
MA-50$350.23
MA-200$341.52
RSI (14)59.5
Avg Volume (30d)2.7M
vs. SPYbeat by 5.4%
Return Rank#351 of 999
Trend Signals
Price is above the 200-day moving average ($341.52)
Price is above the 50-day moving average ($350.23)